Targeting allosteric pockets of SARS-CoV-2 main protease Mpro

被引：14

作者：

Bhat, Zahoor Ahmad ^{[1
]}

Chitara, Dheeraj ^{[2
]}

Iqbal, Jawed ^{[1
]}

Sanjeev, B. S. ^{[2
]}

Madhumalar, Arumugam ^{[1
]}

机构：

[1] Jamia Millia Islamia, Multidisciplinary Ctr Adv Res & Studies, New Delhi, India

[2] Indian Inst Informat Technol, Dept Appl Sci, Allahabad, Uttar Pradesh, India

来源：

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS | 2022年 / 40卷 / 14期

关键词：

SARS-CoV-2; Allostery; molecular dynamics simulations; M-pro protease; Elbasvir; Glecaprevir; Ritonavir; combination therapy; COVID-19;

D O I：

10.1080/07391102.2021.1891141

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Repurposing of antivirals is an attractive therapeutic option for the treatment of COVID-19. Main protease (M-pro ()) , also called 3 C-like protease (3CL(pro)) is a key protease of SARS-CoV-2 involved in viral replication, and is a promising drug target for antivirals. A major challenge to test the efficacy of antivirals is the conformational plasticity of M-pro and its future mutation prone flexibility. Suitable choice of drugs in catalytic and allosteric pockets appear to be essential for combination therapy. Current study, based on docking and extensive set of MD simulations, finds the combination of Elbasvir, Glecaprevir and Ritonavir to be a viable candidate for further experimental drug testing/pharmacophore design for M-pro. Communicated by Ramaswamy H. Sarma

引用

页码：6603 / 6618

页数：16

共 50 条

[1] Elucidation of Cryptic and Allosteric Pockets within the SARS-CoV-2 Main Protease
Sztain, Terra
Amaro, Rommie
McCammon, J. Andrew
[J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2021, 61 (07) : 3495 - 3501
[2] Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yang, Yue
Luo, Yi-Dan
Zhang, Chen-Bo
Xiang, Yang
Bai, Xin-Yue
Zhang, Die
Fu, Zhao-Ying
Hao, Ruo-Bing
Liu, Xiao-Long
[J]. ACS OMEGA, 2024, 9 (32): : 34196 - 34219
[3] In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
Sharma, Shilpa
Deep, Shashank
[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07): : 3003 - 3010
[4] Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro
Jan, Zainab
Geethakumari, Anupriya M.
Biswas, Kabir H.
Jithesh, Puthen Veettil
[J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2023, 21 : 3665 - 3671
[5] Allosteric inhibitors of the main protease of SARS-CoV-2
Samrat, Subodh Kumar
Xu, Jimin
Xie, Xuping
Gianti, Eleonora
Chen, Haiying
Zou, Jing
Pattis, Jason G.
Elokely, Khaled
Lee, Hyun
Li, Zhong
Klein, Michael L.
Shi, Pei-Yong
Zhou, Jia
Li, Hongmin
[J]. ANTIVIRAL RESEARCH, 2022, 205
[6] Allosteric Hotspots in the Main Protease of SARS-CoV-2
Stromich, Leonie
Wu, Nan
Barahona, Mauricio
Yaliraki, Sophia N.
[J]. JOURNAL OF MOLECULAR BIOLOGY, 2022, 434 (17)
[7] Primer for Designing Main Protease (Mpro) Inhibitors of SARS-CoV-2
Thakur, Abhishek
Sharma, Gaurav
Badavath, Vishnu Nayak
Jayaprakash, Venkatesan
Merz, Kenneth M., Jr.
Blum, Galia
Acevedo, Orlando
[J]. JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2022, 13 (25): : 5776 - 5786
[8] A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis
Fatima, Asma
Geethakumari, Anupriya M.
Ahmed, Wesam S.
Biswas, Kabir H.
[J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
[9] Allosteric Modulation of the Main Protease (MPro) of SARS-CoV-2 by Casticin—Insights from Molecular Dynamics Simulations
Jehoshaphat Oppong Mensah
Gilbert Boadu Ampomah
Edward Ntim Gasu
Abigail Kusiwaa Adomako
Elliott Sarpong Menkah
Lawrence Sheringham Borquaye
[J]. Chemistry Africa, 2022, 5 : 1305 - 1320
[10] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
Soumya Gulab Katre
Alpana Jagdish Asnani
Kumar Pratyush
Nilima Gangadhar Sakharkar
Ashwini Gajanan Bhope
Kanchan Tekram Sawarkar
Vaibhav Santosh Nimbekar
[J]. Future Journal of Pharmaceutical Sciences, 8

← 1 2 3 4 5 →